Targeted Tumor Therapies at a Glance
Journal:
Current Drug Targets
Volume:
10
Page:
89-93
Author(s):
H. Fuchs and C. Bachran
Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
Journal:
Current Drug Targets
Volume:
10
Page:
94-103
Author(s):
E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich
Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
Journal:
Current Drug Targets
Volume:
10
Page:
104-109
Author(s):
A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo
Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
Journal:
Current Drug Targets
Volume:
10
Page:
110-117
Author(s):
B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop
Saponins as Tool for Improved Targeted Tumor Therapies
Journal:
Current Drug Targets
Volume:
10
Page:
140-151
Author(s):
H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran
Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Journal:
Current Drug Targets
Volume:
10
Page:
158-175
Author(s):
P. M. Deckert
Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
753-779
Author(s):
P. Nieri, D. Donadio, S. Rossi, B. Adinolfi and A. Podesta
Stereoselectivity in Drug Metabolism: Molecular Mechanisms and Analytical Methods
Journal:
Current Drug Metabolism
Volume:
10
Page:
188-205
Author(s):
Vanessa L. Campo, Lilian S.C. Bernardes and Ivone Carvalho
Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Journal:
Current Rheumatology Reviews
Volume:
5
Page:
58-63
Author(s):
Pavel Horak, Josef Zadrazil, Hana Ciferska and Zuzana Hermanova
Immune Receptors, Cadherins and their Interactions
Journal:
Current Immunology Reviews (Discontinued)
Volume:
5
Page:
2-9
Author(s):
Cindy Banh and Laurent Brossay